Core Insights - The company has a long-standing commitment to the Chinese market, emphasizing its rapid development and the talent of its people [1][2] - China has become the largest single market for the company since 2021, with over 7,000 employees in the country [1][2] Investment and Expansion - The company is increasing its investment in China, with significant projects such as the Suzhou R&D manufacturing base set to launch in 2024 and the acquisition of land in Shanghai for its largest infrastructure investment in China to date [2] - The company aims to enhance its local presence and support high-quality development across various industries in China [2] Strategic Partnerships and Innovation - The company signed a memorandum of understanding with the Shanghai Science and Technology Entrepreneurship Center, joining the Shanghai innovation network to participate in regional technological development [2] - The company is committed to integrating its innovations into the global supply chain while promoting cross-sector innovation ecosystems [2] Financial Performance - In the fiscal year 2023/24, the company reported nearly €11 billion in revenue, covering four major business sectors: industrial quality and research, medical technology, optical consumer products, and semiconductor manufacturing technology [2]